Botox treatment of abdominal wall hernia
- Conditions
- abdominal wall hernia
- Registration Number
- JPRN-jRCTs041230054
- Lead Sponsor
- Saito Takuya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
1) For this study, patients with abdominal wall hernias with a hernia portal of 5 cm or more.
2) Patients with indications for abdominal wall hernia repair based on the preoperative evaluation.
3) Patients who are willing to comply with the research protocol.
4) Patients have signed a consent document approved by the Clinical Research Review Committee regarding participation in the study.
1) Patients with active cancer. However, active cancer does not include intraepithelial carcinoma or lesions equivalent to intramucosal carcinoma that is considered curable by local treatment.
2) Patients with systemic muscle disease (myasthenia gravis, Lambert-Eaton syndrome, amyotrophic lateral sclerosis, etc.).
3) Women who may be pregnant or are lactating.
4) Patients who are allergic to Botox.
5) Patients with severe psychosis or psychiatric symptoms that make it difficult for them to participate in the study.
6) Patients who are deemed ineligible for surgery.
7) Patients with a serious medical condition that would make it inappropriate for the investigator to participate in the study.
8) Patients with a history of abdominal surgery that is inoperable.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Recurrence rate at 1 year
- Secondary Outcome Measures
Name Time Method Operating time, postoperative hospital stay, NRS (Numerical rating scale), SSI (Surgical site infection), seroma, mesh size, hernia portal measurement